Although further studies are necessary to clarify these mechanisms (Trusolino et al, 2001), these studies on the HGF/c-Met pathway will aid the development of new therapeutic strategies for the treatment of NSCLC cancer patients. The gene discussed is MET; the disease is non-small cell lung carcinoma.